Hercules Capital (NYSE:HTGC) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.36 by 8.33 percent. This is a 18.18 percent increase over earnings of $0.33 per share from the
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.
Experts are predicting growth in the US crude oil production in 2023 and beyond. Recently, the U.S. Energy Information Administration (EIA) reported that they expect new milestones for U.S. crude oil production amid